The approval is one of the most fruitful resolutions that resulted from the 58th session of the council, health minister Khaled Abdel-Ghaffar said.
Establishing the agency -- whose headquarters will be located in Egypt -- will achieve pharmaceutical sustainability in all Arab countries through the creation of new markets for pharmaceuticals manufactured in Arab states, he asserted.
Such an initiative will support Arab economies as well as achieve economic growth for all the countries, Abdel-Ghaffar continued.
The agency will support supreme pharmaceutical authorities without contradicting any Arab country’s domestic laws, he assured.
The authorities will coordinate and collaborate to achieve the planned Arab entity goals as well as discuss all technical details, the health minister added.
Egypt is fully prepared to undertake all establishment procedures for the agency, Abdel-Ghaffar confirmed.